Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
...
Next
(1)
•••
sakinny3
X
View Profile
View Bullboard History
Post by
sakinny3
on Dec 08, 2022 9:07am
News Out
Anti aging clinical trail started 5th December, 12 weeks as usual so hopefully some insights to performance in March latest
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 08, 2022 9:00am
New Press Release - Sirona Biochem Announces Start of Clinical Trial for Anti-Aging Compound TFC-1326
VANCOUVER, British Columbia, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce that the clinical trial, for novel anti-aging compound TFC-1326, started on December 5th, 2022. The trial, which will take place in Paris,...
read article.
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Dec 07, 2022 5:00pm
RE:RE:RE:RE:RE:Some News
yes, Agree. full turn key package to make an informed decision.
(4)
•••
str8goods4achg
X
View Profile
View Bullboard History
Comment by
str8goods4achg
on Dec 07, 2022 4:57pm
RE:RE:RE:RE:Some News
@Pareto8020 I posted this Nov 23 in response to their NR. Sirona now has access to all the Wanbang data and it means partners can manufacture themselves or make other arrangements if they want
...more
(43)
•••
SironaInvestor
X
View Profile
View Bullboard History
Comment by
SironaInvestor
on Dec 07, 2022 2:37pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Some News
How do you interpret junior? In terms of revenue or how long the company already trades on the public exchange?
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Dec 07, 2022 2:16pm
RE:RE:RE:RE:RE:RE:RE:RE:Some News
yeah but it is a junior penny stock on the venture. They do the minimum required to maintain compliance with securities regulations.
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Dec 07, 2022 1:48pm
RE:RE:RE:RE:RE:RE:RE:Some News
You know this is a publicly traded security right?
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Dec 07, 2022 12:24pm
RE:RE:RE:RE:RE:RE:Some News
You know this is not a blue chip.
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Dec 07, 2022 12:12pm
RE:RE:RE:RE:RE:Some News
Wrong! The timing isn't irrelevant- it shows SBM doesn't put shareholders interest as a priority and further indicates they don't want to be held accountable to the shareholders.
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Dec 07, 2022 11:59am
RE:RE:RE:RE:Some News
This has never been an event to present or vote on strategic business. So get over it. The date is meaningless. It is purely a secretarial reaffirmation of governance appointments. The better
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Dec 07, 2022 11:28am
RE:RE:RE:Some News
Having an AGM in December next to New Years or Christmas symbolizes all the things wrong with Sirona. What shareholder value comes with conducting an AGM with no conference call over the Christmas
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Dec 06, 2022 3:30pm
RE:RE:RE:RE:Some News
China permitted early generics like the evidence based Empaglifozin to enter the market. Molecules omnin the research shelff like Wannabangaflozin with sirona didn't stand a chance.
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Dec 06, 2022 3:21pm
RE:RE:RE:Some News
Yeah I'm not a big fan of increasing their reliance on a China based company. Not on an idiotic rascist basis but due to past performance (they took so long with clinical trial it went
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Dec 06, 2022 3:13pm
RE:RE:RE:Some News
I think the primary reason for AGM at such an awkvard date is not to avoid shareholders, but to raise the probability for a positive news release before the meeting. However, avoiding shareholders
...more
Prev
...
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario